122 related articles for article (PubMed ID: 9435152)
21. Risk of renal cell carcinoma and polymorphism in phase I xenobiotic metabolizing CYP1A1 and CYP2D6 enzymes.
Ahmad ST; Arjumand W; Seth A; Nafees S; Rashid S; Ali N; Hamiza OO; Sultana S
Urol Oncol; 2013 Oct; 31(7):1350-7. PubMed ID: 22281432
[TBL] [Abstract][Full Text] [Related]
22. Environmental and chemical carcinogenesis.
Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
[TBL] [Abstract][Full Text] [Related]
23. Synergistic association of CYP1A1 polymorphisms with increased susceptibility to squamous cell lung cancer in north Indian smokers.
Girdhar Y; Singh N; Behera D; Sharma S
Int J Biol Markers; 2016 Dec; 31(4):e402-e412. PubMed ID: 27396354
[TBL] [Abstract][Full Text] [Related]
24. Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer.
Shah PP; Singh AP; Singh M; Mathur N; Pant MC; Mishra BN; Parmar D
Mutat Res; 2008 Mar; 639(1-2):1-10. PubMed ID: 18082227
[TBL] [Abstract][Full Text] [Related]
25. CYP1A1.
Kawajiri K
IARC Sci Publ; 1999; (148):159-72. PubMed ID: 10493257
[TBL] [Abstract][Full Text] [Related]
26. CYP1A1 gene polymorphisms and smoking status as modifier factors for lung cancer risk.
Hussein AG; Pasha HF; El-Shahat HM; Gad DM; Toam MM
Gene; 2014 May; 541(1):26-30. PubMed ID: 24613751
[TBL] [Abstract][Full Text] [Related]
27. Risk modification by CYP1A1 and GSTM1 polymorphisms in the association of environmental tobacco smoke and lung cancer: a case-control study in Japanese nonsmoking women.
Kiyohara C; Wakai K; Mikami H; Sido K; Ando M; Ohno Y
Int J Cancer; 2003 Oct; 107(1):139-44. PubMed ID: 12925969
[TBL] [Abstract][Full Text] [Related]
28. Genetic polymorphisms of cytochrome P450 CYP1A1 (*2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: a study from North India.
Srivastava DS; Mandhani A; Mittal RD
Arch Toxicol; 2008 Sep; 82(9):633-9. PubMed ID: 18200441
[TBL] [Abstract][Full Text] [Related]
29. GSTM1 and CYP1A1 polymorphisms, tobacco, air pollution, and lung cancer: a study in rural Thailand.
Pisani P; Srivatanakul P; Randerson-Moor J; Vipasrinimit S; Lalitwongsa S; Unpunyo P; Bashir S; Bishop DT
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):667-74. PubMed ID: 16614107
[TBL] [Abstract][Full Text] [Related]
30. [Study on serum organochlorines pesticides (DDTs) level, CYP1A1 genetic polymorphism and risk of breast cancer: a case control study].
Li JY; Wu DS; Yang F; Zeng HY; Lei FM; Zhou WD; Li H; Tao P
Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Mar; 27(3):217-22. PubMed ID: 16792888
[TBL] [Abstract][Full Text] [Related]
31. CYP1A1, cigarette smoking, and colon and rectal cancer.
Slattery ML; Samowtiz W; Ma K; Murtaugh M; Sweeney C; Levin TR; Neuhausen S
Am J Epidemiol; 2004 Nov; 160(9):842-52. PubMed ID: 15496536
[TBL] [Abstract][Full Text] [Related]
32. CYP1A1 polymorphisms and risk of lung cancer in the ethnic Kashmiri population.
Shaffi SM; Shah MA; Bhat IA; Koul P; Ahmad SN; Siddiqi MA
Asian Pac J Cancer Prev; 2009; 10(4):651-6. PubMed ID: 19827888
[TBL] [Abstract][Full Text] [Related]
33. Gene-environment interactions in human lung cancer.
Haugen A; Ryberg D; Mollerup S; Zienolddiny S; Skaug V; Svendsrud DH
Toxicol Lett; 2000 Mar; 112-113():233-7. PubMed ID: 10720736
[TBL] [Abstract][Full Text] [Related]
34. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens.
Le Marchand L; Sivaraman L; Pierce L; Seifried A; Lum A; Wilkens LR; Lau AF
Cancer Res; 1998 Nov; 58(21):4858-63. PubMed ID: 9809991
[TBL] [Abstract][Full Text] [Related]
35. [Using MSR model to analyze the impact of gene-gene interaction with related to the genetic polymorphism of metabolism enzymes on the risk of breast cancer].
Li JY; Long QM; Tao P; Hu R; Li H; Lei FM; Zhou WD; Li SF
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):780-3, 787. PubMed ID: 19024313
[TBL] [Abstract][Full Text] [Related]
36. CYP1A1 Ile462Val polymorphism and the risk of non-small cell lung cancer in a Chinese population.
Lin J; He B; Cao L; Zhang Z; Liu H; Rao J; Liu Y; Shao S; Wang G; Zhang X
Tumori; 2014; 100(5):547-52. PubMed ID: 25343551
[TBL] [Abstract][Full Text] [Related]
37. Polychlorinated biphenyls, cytochrome P4501A1 polymorphism, and postmenopausal breast cancer risk.
Moysich KB; Shields PG; Freudenheim JL; Schisterman EF; Vena JE; Kostyniak P; Greizerstein H; Marshall JR; Graham S; Ambrosone CB
Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):41-4. PubMed ID: 9950238
[TBL] [Abstract][Full Text] [Related]
38. GSTM1, GSTT1 and CYP1A1 detoxification gene polymorphisms and susceptibility to smoking-related coronary artery disease: a case-only study.
Manfredi S; Federici C; Picano E; Botto N; Rizza A; Andreassi MG
Mutat Res; 2007 Aug; 621(1-2):106-12. PubMed ID: 17408703
[TBL] [Abstract][Full Text] [Related]
39. Polymorphisms of the CYP1A1, CYP2E1 and XRCC1 genes and cancer risk in a Southern Italian population: a case-control study.
Bianchino G; Cittadini A; Grieco V; Traficante A; Zupa A; Improta G; Aieta M; Sgambato A
Anticancer Res; 2011 Apr; 31(4):1359-65. PubMed ID: 21508386
[TBL] [Abstract][Full Text] [Related]
40. Combined effects of genetic polymorphisms in six selected genes on lung cancer susceptibility.
Yang M; Choi Y; Hwangbo B; Lee JS
Lung Cancer; 2007 Aug; 57(2):135-42. PubMed ID: 17428572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
